CIK 0001104506
- Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- EIN
- 541972729
- Phone
- +1 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,100,000
- in 1 filing
Net −$3,100,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-15 | Lewis William Chair and CEO | Sale 10b5-1 | −631 | $71.01 | $45K | 233,924 |
| 2025-01-15 | Lewis William Chair and CEO | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −18,750 | 75,000 | ||
| 2025-01-15 | Lewis William Chair and CEO | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −6,830 | 218,630 | ||
| 2025-01-14 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −1,384 | $68.72 | $95K | 100,165 |
| 2025-01-14 | Adsett Roger Chief Operating Officer | Sale 10b5-1 | −1,457 | $68.72 | $100K | 146,082 |
| 2025-01-14 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale 10b5-1 | −872 | $68.72 | $60K | 97,083 |
| 2025-01-10 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −1,371 | $63.73 | $87K | 106,350 |
| 2025-01-10 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −4,801 | $63.62 | $305K | 101,549 |
| 2025-01-10 | Bonstein Sara Chief Financial Officer | Sale | −1,066 | $63.72 | $68K | 118,863 |
| 2025-01-10 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale 10b5-1 | −965 | $63.87 | $62K | 101,047 |
| 2025-01-10 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale 10b5-1 | −3,092 | $63.62 | $197K | 97,955 |
| 2025-01-10 | Wise John Drayton Chief Commercial Officer | Sale 10b5-1 | −287 | $65.40 | $19K | 125,562 |
| 2025-01-10 | Lewis William Chair and CEO | Sale | −2,978 | $63.36 | $189K | 392,589 |
| 2025-01-10 | Smith Michael Alexander Chief Legal Officer | Sale | −319 | $63.38 | $20K | 69,965 |
| 2025-01-10 | Adsett Roger Chief Operating Officer | Sale 10b5-1 | −1,298 | $63.86 | $83K | 151,143 |
| 2025-01-10 | Adsett Roger Chief Operating Officer | Sale 10b5-1 | −3,604 | $63.62 | $229K | 147,539 |
| 2025-01-08 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −1,702 | $66.16 | $113K | 101,064 |
| 2025-01-08 | Flammer Martina M.D. Chief Medical Officer | Grant or award 10b5-1 | +6,657 | 107,721 | ||
| 2025-01-08 | Flammer Martina M.D. Chief Medical Officer | Grant or award · Stock Option (right to buy) 10b5-1 | +31,930 | 31,930 | ||
| 2025-01-08 | Bonstein Sara Chief Financial Officer | Sale | −1,464 | $66.05 | $97K | 113,272 |
Page 32 of 42 · 826 trades